Table of Contents
ISRN Pharmacology
Volume 2012 (2012), Article ID 707932, 11 pages
http://dx.doi.org/10.5402/2012/707932
Research Article

Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl- and Thioxo-1,2,4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors

1Department of Pharmaceutical Sciences, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan
2Department of Chemistry, Quaid-i-Azam University, Islamabad 45320, Pakistan
3Zhang Initiative Research Unit, Advanced Science Institute, RIKEN, 2-1 Hirosawa, Saitama, Wako 351-0198, Japan

Received 6 April 2012; Accepted 17 May 2012

Academic Editors: R. J. Beninger, M. C. Olianas, M. Tohda, and R. Trullas

Copyright © 2012 Ahsan Raza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. V. Terry Jr. and J. J. Buccafusco, “The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development,” Journal of Pharmacology and Experimental Therapeutics, vol. 306, no. 3, pp. 821–827, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Waldemar, B. Dubois, M. Emre et al., “Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline,” European Journal of Neurology, vol. 14, no. 1, pp. e1–e26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. R. T. Bartus, R. L. Dean III, B. Beer, and A. S. Lippa, “The cholinergic hypothesis of geriatric memory dysfunction,” Science, vol. 217, no. 4558, pp. 408–414, 1982. View at Google Scholar · View at Scopus
  4. M. Weinstock, “Possible role of the cholinergic system and disease models,” Journal of Neural Transmission, Supplement, no. 49, pp. 93–102, 1997. View at Google Scholar · View at Scopus
  5. S. B. Dunnett and H. C. Fibiger, “Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia,” Progress in Brain Research, vol. 98, pp. 413–420, 1993. View at Google Scholar · View at Scopus
  6. M. R. Roberson and L. E. Harrell, “Cholinergic activity and amyloid precursor protein metabolism,” Brain Research Reviews, vol. 25, no. 1, pp. 50–69, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. W. W. Pendlebury and P. R. Solomon, “Alzheimer's disease: therapeutic strategies for the 1990s,” Neurobiology of Aging, vol. 15, no. 2, pp. 287–289, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. N. C. Inestrosa, A. Alvarez, C. A. Pérez et al., “Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme,” Neuron, vol. 16, no. 4, pp. 881–891, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Hardy and D. J. Selkoe, “The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics,” Science, vol. 297, no. 5580, pp. 353–356, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Weinstock, “Selectivity of cholinesterase inhibition: clinical implications for the treatment of Alzheimer's disease,” CNS Drugs, vol. 12, no. 4, pp. 307–323, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Zhou, X. B. Wang, T. Wang, and L. Y. Kong, “Design, synthesis, and acetylcholinesterase inhibitory activity of novel coumarin analogues,” Bioorganic and Medicinal Chemistry, vol. 16, no. 17, pp. 8011–8021, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Brühlmann, F. Ooms, P. A. Carrupt et al., “Coumarins derivatives as dual inhibitors of acetylcholinesterase and monoamine oxidase,” Journal of Medicinal Chemistry, vol. 44, no. 19, pp. 3195–3198, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. R. G. Kalkhambkar, G. M. Kulkarni, C. M. Kamanavalli, N. Premkumar, S. M. B. Asdaq, and C. M. Sun, “Synthesis and biological activities of some new fluorinated coumarins and 1-aza coumarins,” European Journal of Medicinal Chemistry, vol. 43, no. 10, pp. 2178–2188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Smyth, V. N. Ramachandran, and W. F. Smyth, “A study of the antimicrobial activity of selected naturally occurring and synthetic coumarins,” International Journal of Antimicrobial Agents, vol. 33, no. 5, pp. 421–426, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Belluti, G. Fontana, L. D. Bo, N. Carenini, C. Giommarelli, and F. Zunino, “Design, synthesis and anticancer activities of stilbene-coumarin hybrid compounds: Identification of novel proapoptotic agents,” Bioorganic and Medicinal Chemistry, vol. 18, no. 10, pp. 3543–3550, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. J. R. S. Hoult and M. Payá, “Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential,” General Pharmacology, vol. 27, no. 4, pp. 713–722, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. B. H. Lee, M. F. Clothier, F. E. Dutton, G. A. Conder, and S. S. Johnson, “Anthelmintic β-hydroxyketoamides (BKAS),” Bioorganic and Medicinal Chemistry Letters, vol. 8, no. 23, pp. 3317–3320, 1998. View at Google Scholar · View at Scopus
  18. J. R. Hwu, R. Singha, S. C. Hong et al., “Synthesis of new benzimidazole-coumarin conjugates as anti-hepatitis C virus agents,” Antiviral Research, vol. 77, no. 2, pp. 157–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Edenharder, C. Speth, M. Decker, H. Kolodziej, O. Kayser, and K. L. Platt, “Inhibition of mutagenesis of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) by coumarins and furanocoumarins, chromanones and furanochromanones,” Mutation Research, vol. 345, no. 1-2, pp. 57–71, 1995. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Manvar, A. Malde, J. Verma et al., “Synthesis, anti-tubercular activity and 3D-QSAR study of coumarin-4-acetic acid benzylidene hydrazides,” European Journal of Medicinal Chemistry, vol. 43, no. 11, pp. 2395–2403, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. W. J. L. Wood, A. W. Patterson, H. Tsuruoka, R. K. Jain, and J. A. Ellman, “Substrate activity screening: a fragment-based method for the rapid identification of nonpeptidic protease inhibitors,” Journal of the American Chemical Society, vol. 127, no. 44, pp. 15521–15527, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Radanyi, G. Le Bras, S. Messaoudi et al., “Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90),” Bioorganic and Medicinal Chemistry Letters, vol. 18, no. 7, pp. 2495–2498, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Chimenti, D. Secci, A. Bolasco et al., “Inhibition of monoamine oxidases by coumarin-3-acyl derivatives: biological activity and computational study,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 14, pp. 3697–3703, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Starcevic, P. Kocbek, G. Hribar, T. Lanišnik, and S. Gobec, “Biochemical and biological evaluation of novel potent coumarin inhibitor of 17β-HSD type 1,” Chemico-Biological Interactions, vol. 191, no. 1-3, pp. 60–65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. J. F. Cheng, A. Ishikawa, Y. Ono et al., “Novel chromene derivatives as TNF-α inhibitors?” Bioorganic & Medicinal Chemistry Letters, vol. 13, no. 21, pp. 3647–3650, 2003. View at Google Scholar
  26. H. G. Raj, V. S. Parmar, S. C. Jain et al., “Mechanism of biochemical action of substituted 4-methylbenzopyran-2-ones. Part I: dioxygenated 4-methylcoumarins as superb antioxidant and radical scavenging agents,” Bioorganic and Medicinal Chemistry, vol. 6, no. 6, pp. 833–839, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Andreani, M. Rambaldi, A. Leoni et al., “Potential antitumor agents. 24. Synthesis and pharmacological behavior of imidazo[2,1-b]thiazole guanylhydrazones bearing at least one chlorine,” Journal of Medicinal Chemistry, vol. 39, no. 14, pp. 2852–2855, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. F. W. Bell, A. S. Cantrell, M. Hogberg et al., “Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs,” Journal of Medicinal Chemistry, vol. 38, no. 25, pp. 4929–4936, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. R. G. Kalkhambkar, G. M. Kulkarni, H. Shivkumar, and R. N. Rao, “Synthesis of novel triheterocyclic thiazoles as anti-inflammatory and analgesic agents,” European Journal of Medicinal Chemistry, vol. 42, no. 10, pp. 1272–1276, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Rudolph, H. Theis, R. Hanke, R. Endermann, L. Johannsen, and F. U. Geschke, “seco-Cyclothialidines: new concise synthesis, inhibitory activity toward bacterial and human DNA topoisomerases, and antibacterial properties,” Journal of Medicinal Chemistry, vol. 44, no. 4, pp. 619–626, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Geronikaki, D. Hadjipavlou-Litina, A. Zablotskaya, and I. Segal, “Organosilicon-containing thiazole derivatives as potential lipoxygenase inhibitors and anti-inflammatory agents,” Bioinorganic Chemistry and Applications, vol. 2007, Article ID 92145, 7 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Saeed and A. Ibrar, “Synthesis of some new 3-(5-(Arylamino)-1,3,4-thiadiazol-2-yl)-2H-chromen-2-ones and 3-(4-Aryl-5-thioxo-4, 5-dihydro-1H-1,2,4-triazol-3-YL)-2H-chromen-2-ones,” Phosphorus, Sulfur, and Silicon and the Related Elements, vol. 186, no. 8, pp. 1801–1810, 2011. View at Google Scholar
  33. H. Nakano, T. Inoue, N. Kawasaki et al., “Synthesis and biological activities of novel antiallergic agents with 5- lipoxygenase inhibiting action,” Bioorganic and Medicinal Chemistry, vol. 8, no. 2, pp. 373–380, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. C. T. Supuran, C. W. Conroy, and T. H. Maren, “Carbonic anhydrase inhibitors: synthesis and inhibitory properties of 1,3,4-thiadiazole-2,5-bissulfonamide,” European Journal of Medicinal Chemistry, vol. 31, no. 11, pp. 843–846, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Darvesh, D. A. Hopkins, and C. Geula, “Neurobiology of butyrylcholinesterase,” Nature Reviews Neuroscience, vol. 4, no. 2, pp. 131–138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. G. L. Warren, C. W. Andrews, A. M. Capelli et al., “A critical assessment of docking programs and scoring functions,” Journal of Medicinal Chemistry, vol. 49, no. 20, pp. 5912–5931, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. K. P. Mintz and S. Brimijoin, “Two-step immunoaffinity purification of acetylcholinesterase from rabbit brain,” Journal of Neurochemistry, vol. 44, no. 1, pp. 225–232, 1985. View at Google Scholar · View at Scopus
  38. G. L. Ellman, K. D. Courtney, V. Andres, and R. M. Featherstone, “A new and rapid colorimetric determination of acetylcholinesterase activity,” Biochemical Pharmacology, vol. 7, no. 2, pp. 88–95, 1961. View at Google Scholar · View at Scopus
  39. K. Ingkaninan, C. M. de Best, R. van der Heijden et al., “High-performance liquid chromatography with on-line coupled UV, mass spectrometric and biochemical detection for identification of acetylcholinesterase inhibitors from natural products,” Journal of Chromatography A, vol. 872, no. 1-2, pp. 61–73, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. G. Jones, P. Willett, R. C. Glen, A. R. Leach, and R. Taylor, “Development and validation of a genetic algorithm for flexible docking,” Journal of Molecular Biology, vol. 267, no. 3, pp. 727–748, 1997. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Wu and Y. Zhang, “LOMETS: a local meta-threading-server for protein structure prediction,” Nucleic Acids Research, vol. 35, no. 10, pp. 3375–3382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Wu, J. Skolnick, and Y. Zhang, “Ab initio modeling of small proteins by iterative TASSER simulations,” BMC Biology, vol. 5, article 17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Zhang and J. Skolnick, “SPICKER: a clustering approach to identify near-native protein folds,” Journal of Computational Chemistry, vol. 25, no. 6, pp. 865–871, 2004. View at Publisher · View at Google Scholar · View at Scopus